Siegfried (SIX: SFZN), a global Contract Development and Manufacturing Organization (CDMO), announced the appointment of Eduardo Montanha as Chief Operating Officer and member of the Executive Committee, effective September 1, 2026. The move follows the company's decision to combine the COO roles for Drug Substances and Drug Products into a single position, aligning with its strategy to provide integrated end-to-end solutions across the pharmaceutical value chain.
Montanha brings over 20 years of international leadership experience in pharmaceutical and biopharmaceutical manufacturing. Most recently, he served as Executive Vice President, Head of Global Technical Operations & Quality at Fresenius Kabi, where he led an integrated global network of approximately 30 manufacturing sites across multiple regions. His career also includes senior leadership positions at Takeda, Sandoz, Hexal, and Hoechst/Aventis, covering technical operations, quality, supply, and large-scale manufacturing networks.
In his new role, Montanha will focus on strengthening supply performance, operational efficiency, and reliability across Siegfried's global network. His background in integrated operations is expected to be instrumental in enhancing the company's ability to serve its pharmaceutical clients with seamless solutions from drug substances to finished drug products.
Marcel Imwinkelried, Chief Executive Officer of Siegfried, said: I am very pleased to welcome Eduardo to Siegfried. He brings outstanding global operations and quality leadership experience and will play an important role in further enhancing supply performance, operational efficiency and reliability for our customers.
Montanha holds a bachelor's degree in chemical engineering, a postgraduate qualification in Industrial Automation, and an MBA in Project Management. He has lived and worked across Europe and Latin America, adding to his international perspective.
The appointment underscores Siegfried's commitment to operational excellence as it continues to expand its global footprint. The company operates 16 sites in Switzerland, Germany, Spain, France, Malta, the USA, Australia, and China, employing more than 3,800 people. In 2025, Siegfried reported sales of CHF 1,327.8 million. The company is publicly listed on the SIX Swiss Exchange (SIX: SFZN).
For more information about Siegfried's operations and strategy, visit www.siegfried.ch.
